Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 325,286 | 112,000 | 117,311 | 207,075 | 250,321 |
| Marketable Securities | 153,767 | 194,337 | 186,328 | 134,255 | 129,475 |
| Receivables | 82,287 | 95,196 | 71,858 | 65,568 | 67,766 |
| TOTAL | $575,719 | $417,750 | $395,444 | $425,508 | $461,594 |
| Non-Current Assets | |||||
| PPE Net | 318,498 | 292,329 | 274,621 | 259,676 | 215,169 |
| Investments And Advances | 37,956 | 70,465 | 108,278 | 47,080 | 57,200 |
| Other Non-Current Assets | 10,260 | 10,097 | 8,813 | 8,938 | 8,229 |
| TOTAL | $366,714 | $372,891 | $391,712 | $315,694 | $280,598 |
| Total Assets | $942,433 | $790,641 | $787,156 | $741,202 | $742,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 74,976 | 58,256 | 53,905 | 49,031 | 55,291 |
| TOTAL | $133,833 | $119,571 | $104,093 | $93,575 | $114,165 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 58,223 | 60,867 | 49,753 | 44,544 | 58,874 |
| Other Non-Current Liabilities | 5,289 | 4,318 | 4,140 | 3,959 | 3,341 |
| TOTAL | $460,536 | $299,854 | $296,792 | $250,865 | $205,584 |
| Total Liabilities | $594,369 | $419,425 | $400,885 | $344,440 | $319,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,293 | 82,113 | 81,913 | 81,653 | 80,494 |
| Common Shares | 82 | 82 | 82 | 79 | 80 |
| Retained earnings | -1,030,966 | -997,091 | -971,617 | -941,095 | -904,606 |
| Other shareholders' equity | -175 | -306 | 717 | 1,046 | 3,537 |
| TOTAL | $348,064 | $371,216 | $386,271 | $396,762 | $422,443 |
| Total Liabilities And Equity | $942,433 | $790,641 | $787,156 | $741,202 | $742,192 |